Legend Biotech Corp LEGN

US Biotechnology

$18.55 ▼ -2.62% ($-0.50)

🗓️ Earnings Next Week

Open $18.79

Prev Close $19.05

Day Range $18.33 – $19.00

52W Range $16.24 – $40.05

Market Cap $3.54B

Beta 0.38

EPS (TTM) $-0.68

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2020-06-04
Shares Out.	386,880,000
Website	investors.legendbiotech.com/ ↗
Phone	17328505598
Employees	2,900
Total Assets	$1.73B
Total Liabilities	$731.6M
Equity	$1.00B

About Legend Biotech Corp

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Legend Biotech Corp is a publicly traded company under the ticker symbol LEGN on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.